A Phase II Study in Patients With Alopecia Areata

NCT04346316 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: SHR0302

Sponsor

Reistone Biopharma Company Limited